Financhill
Back

CytoMed Therapeutics Ltd. Stock Predictions

CytoMed Therapeutics Ltd. Stock Forecast

  • Is CytoMed Therapeutics Ltd. Stock Undervalued?
    The current CytoMed Therapeutics Ltd. [GDTC] share price is $1.41. The Score for GDTC is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • GDTC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will CytoMed Therapeutics Ltd. Stock Go Up Next Year?

Data Unavailable

CytoMed Therapeutics Ltd. Stock Rating

Data Unavailable

CytoMed Therapeutics Ltd. Stock Price History

Is GDTC stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GDTC is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Singapore
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cytomed.sg

52-Week Data

52-Week High:
4.05
52-Week Low:
1.38

Prediction Charts

Market Cap:
16.5M
Price in USD:
1.41
Volume:
57.3K
Beta:
-0.30

Technical Analysis

SMA50:
1.98
SMA100:
1.96
SMA200:
2.12
52-Wk Change:
-42.21%

Stock Predictions

  • Is CytoMed Therapeutics Ltd. stock public?
    Yes, CytoMed Therapeutics Ltd. is a publicly traded company.
  • What is the CytoMed Therapeutics Ltd. stock quote today?
    The CytoMed Therapeutics Ltd. stock price is 1.41 USD today.
  • How to buy CytoMed Therapeutics Ltd. stock online?
    You can buy CytoMed Therapeutics Ltd. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-2 1.82 1.74 1.82 1.74
Dec-3 1.73 1.75 1.75 1.72
Dec-4 1.75 1.85 1.88 1.75
Dec-5 1.71 1.77 1.80 1.71
Dec-8 1.80 1.85 2.12 1.80
Dec-9 1.85 1.55 1.85 1.50
Dec-10 1.58 1.56 1.72 1.50
Dec-11 1.63 1.67 1.67 1.58
Dec-12 1.66 1.66 1.68 1.63
Dec-15 1.62 1.60 1.64 1.59
Dec-16 1.62 1.62 1.62 1.58
Dec-17 1.66 1.58 1.66 1.53
Dec-18 1.56 1.56 1.62 1.55
Dec-19 1.58 1.41 1.63 1.38

CytoMed Therapeutics Ltd. Earnings

Data Unavailable

CytoMed Therapeutics Ltd. Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and a decrease next year of $0.00 per share.

* CytoMed Therapeutics Ltd. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.